glp 1 effect on kidneys GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists GLP-1 Receptor Agonists in Chronic
Description
Start at 2.5mg weekly for at least four weeks
DM, diabetes mellitus
One notable finding from meta-analyses: cagrilintide demonstrated the lowest odds ratios for nausea, vomiting, and diarrhea when compared to other incretin-based therapies including semaglutide and tirzepatide
Access to existing therapies or development of novel ones
Real progress looks boring on a billboard
Treatment is highly individualized and can be modified based on response
